App aims to help teens and young adults control diabetes
NCT ID NCT07270016
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study is testing a new smartphone app called Healthmine that pairs data from a continuous glucose monitor and a Fitbit. Thirty young adults aged 16-24 who were diagnosed with type 2 diabetes before age 18 will use the app for 30 days. The goal is to see if the app is easy to use and to gather feedback on health behavior messages.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Healthmine smartphone app with continuous glucose monitor and Fitbit
- What this could lead to
- If successful, this could lead to a better tool for helping young adults with type 2 diabetes manage their blood sugar and activity levels.
- What could go wrong
- This is a very small pilot study with only 30 people, so results may not apply to everyone. The app is still being developed and may not be easy to use or effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTINUOUS GLUCOSE MONITORING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospital of Pittsburgh
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a heart drug tame blood sugar and weight in diabetes?
- Can a puff of insulin replace a needle for diabetes?
- Could a quick insulin shot stop Steroid-Induced blood sugar spikes?
- Can a puff of insulin replace a daily shot for diabetes?
- Could a Dairy-Rich diet tame type 2 diabetes?
- Can a traditional herbal remedy tame type 2 diabetes?